How does CNLK's PB Ratio compare to its peers?

Insufficient data to calculate CNLK's Price-To-Book Ratio vs. peers for valuation analysis.

How does CNLK's PB Ratio compare vs other companies in the US Pharmaceuticals Industry?

Insufficient data to calculate CNLK's Price-To-Book Ratio vs. industry for valuation analysis.

What is CNLK's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate CNLK's Price-To-Book Fair Ratio for valuation analysis.

What is the Fair Price of CNLK when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Insufficient data to calculate CNLK's fair value for valuation analysis.

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

Cannalink OTCPK:CNLK Stock Report

Last Price

US$0.0002

Market Cap

US$0

7D

0%

1Y

0%

Updated

21 May, 2024

Data

Company Financials

Cannalink, Inc.

OTCPK:CNLK Stock Report

Market Cap: US$0

CNLK Stock Overview

A development stage company that intends to develop cannabidiol based products and provide services to emerging companies in the medical marijuana and industrial healthcare sector. More details

CNLK fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Shares are highly illiquid

Does not have a meaningful market cap ($0)

Has not reported any financial data

My Notes

Capture your thoughts, links and company narrative

Cannalink, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Cannalink
Historical stock prices
Current Share Price	US$0.0002
52 Week High	US$0.0002
52 Week Low	US$0.0002
Beta	0
1 Month Change	0%
3 Month Change	n/a
1 Year Change	0%
3 Year Change	n/a
5 Year Change	-99.96%
Change since IPO	-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	CNLK	US Pharmaceuticals	US Market
7D	0%	-1.7%	-2.6%
1Y	0%	3.2%	24.5%

Return vs Industry: CNLK underperformed the US Pharmaceuticals industry which returned 15.2% over the past year.

Return vs Market: CNLK underperformed the US Market which returned 26.1% over the past year.

Price Volatility

Is CNLK's price volatile compared to industry and market?
CNLK volatility
CNLK Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	10.5%
Market Average Movement	6.3%
10% most volatile stocks in US Market	17.7%
10% least volatile stocks in US Market	3.1%

Stable Share Price: CNLK has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine CNLK's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	n/a	n/a	www.cannalink.us

Cannalink, Inc. is a development stage company that intends to develop cannabidiol based products and provide services to emerging companies in the medical marijuana and industrial healthcare sector. The company is based in San Diego, California.

Cannalink, Inc. Fundamentals Summary

How do Cannalink's earnings and revenue compare to its market cap?
CNLK fundamental statistics
Market cap	n/a
Earnings (TTM)	US$0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is CNLK overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CNLK income statement (TTM)
Revenue	US$0
Cost of Revenue	US$0
Gross Profit	US$0
Other Expenses	US$0
Earnings	US$0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did CNLK perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/05/21 07:55
End of Day Share Price	2024/02/22 00:00
Earnings	N/A
Annual Earnings	N/A

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Cannalink, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution